Autopsy report · NCT03848481
CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)
Cause of deathFunding or business
“Only limited funding was available and the study was never able to be conducted to its natural conclusion.”
Life of this trial
- Registered 1 year 9 months before it started.
- Ran for about 3 years 11 months before it stopped.
- 6 participants enrolled.
- Results were posted on the registry 1 year 6 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Eric Hollander
- Sponsor type
- University, hospital or other
- Conditions
- Prader-Willi Syndrome
- Interventions
- CBDV Compound; Placebo
- Participants
- 6
- Sites
- 1
- Countries
- United States
Trials that died the same way
- A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Bipolar Depression
“Study did not receive funding and was never carried out.” - ITT-5 Mechanisms of Spermatogenesis in Man
“No funding was obtained for this study.” - Effect of Rasagiline on Balance in Parkinson's Disease as Measured by Computerized Posturography
“Funding for the study could not be obtained.” - CBD for Pain Reduction and Opioid Use After Ankle and Tibia Fracture ORIF
“there was no funding to begin the study” - Impact of Nutrition and Swallowing Function of Head and Neck Cancer Patients During the Course of Treatment
“The study did not receive funding.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.